Etofylline

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000519-37-9

Chemical Formula

C9-H12-N4-O3

Molecular Weight

224

Therapeutic Categories

Antiasthmatic agent

Bronchodilator

Non-selective phosphodiesterase inhibitor

Cardiac stimulant

Chemical Name

1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxyetyl)-1,3-dimetyl-

Foreign Names

• Etofyllinum (Latin)
• Etofyllin (German)
• Etofylline (French)
• Etofilina (Spanish)

Generic Names

• Etofillina (OS: DCIT)
• Etofylline (OS: BAN)
• Étofylline (OS: DCF)
• Ascorphylline (IS)
• Hydroxyaethyltheophyllinum (IS)
• Mediphyllin (IS)
• Etofyllin (PH: Ph. Eur. 8)
• Etofylline (PH: BP 2012, Ph. Eur. 8)
• Etofyllinum (PH: Ph. Eur. 8)

Brand Names

• Albutamol [+ Salbutamol, + Bromhexine]
  Centaur, India
• Bronchilet [+ Salbutamol]
  AHPL, India
• Deriphyllin [+ Theophylline]
  Zydus, India; Zydus Cadila, Myanmar
• Deriphyllin Retard [+ Theophylline]
  Zydus, India
• Oxantil [+ Theophylline]
  BB Pharma, Czech Republic; BB Pharma, Slovakia
• Oxyphyllin
  Noventis, Czech Republic; Noventis, Slovakia
• Relasmin [+ Theophylline]
  Tablets, India
• Solphyllin [+ Theophyll]
  Al Pharm, South Africa

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer